Logo image of CVV.CA

CANALASKA URANIUM LTD (CVV.CA) Stock Fundamental Analysis

Canada - TSX-V:CVV - CA13709C1005 - Common Stock

1.09 CAD
-0.04 (-3.54%)
Last: 9/25/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, CVV scores 2 out of 10 in our fundamental rating. CVV was compared to 220 industry peers in the Oil, Gas & Consumable Fuels industry. CVV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CVV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

CVV had negative earnings in the past year.
In the past year CVV has reported a negative cash flow from operations.
In the past 5 years CVV always reported negative net income.
CVV had a negative operating cash flow in each of the past 5 years.
CVV.CA Yearly Net Income VS EBIT VS OCF VS FCFCVV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M

1.2 Ratios

CVV's Return On Assets of -45.53% is on the low side compared to the rest of the industry. CVV is outperformed by 78.18% of its industry peers.
CVV's Return On Equity of -51.64% is on the low side compared to the rest of the industry. CVV is outperformed by 70.91% of its industry peers.
Industry RankSector Rank
ROA -45.53%
ROE -51.64%
ROIC N/A
ROA(3y)-52.11%
ROA(5y)-47.93%
ROE(3y)-61.88%
ROE(5y)-55.3%
ROIC(3y)N/A
ROIC(5y)N/A
CVV.CA Yearly ROA, ROE, ROICCVV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CVV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CVV.CA Yearly Profit, Operating, Gross MarginsCVV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, CVV has more shares outstanding
The number of shares outstanding for CVV has been increased compared to 5 years ago.
The debt/assets ratio for CVV has been reduced compared to a year ago.
CVV.CA Yearly Shares OutstandingCVV.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CVV.CA Yearly Total Debt VS Total AssetsCVV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

CVV has an Altman-Z score of 37.98. This indicates that CVV is financially healthy and has little risk of bankruptcy at the moment.
CVV's Altman-Z score of 37.98 is amongst the best of the industry. CVV outperforms 96.82% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that CVV is not too dependend on debt financing.
CVV has a better Debt to Equity ratio (0.03) than 75.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 37.98
ROIC/WACCN/A
WACCN/A
CVV.CA Yearly LT Debt VS Equity VS FCFCVV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

CVV has a Current Ratio of 10.09. This indicates that CVV is financially healthy and has no problem in meeting its short term obligations.
CVV's Current ratio of 10.09 is amongst the best of the industry. CVV outperforms 93.18% of its industry peers.
CVV has a Quick Ratio of 10.09. This indicates that CVV is financially healthy and has no problem in meeting its short term obligations.
CVV has a better Quick ratio (10.09) than 93.64% of its industry peers.
Industry RankSector Rank
Current Ratio 10.09
Quick Ratio 10.09
CVV.CA Yearly Current Assets VS Current LiabilitesCVV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

0

3. Growth

3.1 Past

The earnings per share for CVV have decreased by -5.59% in the last year.
EPS 1Y (TTM)-5.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.1%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -22.47% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-33.33%
EPS Next 2Y-22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CVV.CA Yearly EPS VS EstimatesCVV.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.02 -0.04 -0.06 -0.08

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVV. In the last year negative earnings were reported.
Also next year CVV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVV.CA Price Earnings VS Forward Price EarningsCVV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVV.CA Per share dataCVV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

A cheap valuation may be justified as CVV's earnings are expected to decrease with -22.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CVV!.
Industry RankSector Rank
Dividend Yield N/A

CANALASKA URANIUM LTD

TSX-V:CVV (9/25/2025, 7:00:00 PM)

1.09

-0.04 (-3.54%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)09-16 2025-09-16
Earnings (Next)12-15 2025-12-15
Inst Owners33.32%
Inst Owner ChangeN/A
Ins Owners3.25%
Ins Owner ChangeN/A
Market Cap205.85M
Analysts83.64
Price Target1.61 (47.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 10.1
P/tB 10.1
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.53%
ROE -51.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.11%
ROA(5y)-47.93%
ROE(3y)-61.88%
ROE(5y)-55.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.01%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.09
Quick Ratio 10.09
Altman-Z 37.98
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)125.08%
Cap/Depr(5y)290.51%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.1%
EPS Next Y-33.33%
EPS Next 2Y-22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-27.16%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.13%
OCF growth 3YN/A
OCF growth 5YN/A